EGFR and neoplasm: Mechanistically, SAH-JGZ4 disturbed the in vivo interactions of EGFR–TRIB3 and EGFR–PKCα, and suppressed the expression of EGFR and PKCα in the inoculated tumor tissues (Fig. 7e).